Department of Tropical Infectious Diseases, Second Military Medical University, Shanghai, 200433, China.
Institute for Infectious Diseases and Vaccine Development, Tongji University School of Medicine, 1239 Siping Road, Shanghai, 200092, China.
Malar J. 2018 Jul 5;17(1):248. doi: 10.1186/s12936-018-2396-0.
Mutations in the Plasmodium falciparum k13 gene are associated with artemisinin (ART) resistance. However, it is unclear whether the F446I mutation, the most prevalent allele at the China-Myanmar border and north of Myanmar, is associated with ART resistance. Therefore, the aim of this study was to investigate the role of this mutation in ART resistance by generating transgenic parasites expressing the F446I mutant allele.
The transgenic parasites carrying the F446I or C580Y mutation in both 3D7 and FCC1/HN isolates were generated by single crossing-over recombination and verified using PCR and gene sequencing. The ring-stage survival assay of 0-3 h (RSA) was used to evaluate ART susceptibility of the transgenic parasites in vitro.
Four transgenic parasite lines named 3D7, 3D7, FCC1/HN and FCC1/HN were successfully generated. These parasite lines showed no changes in the expression level of k13 when compared with their parent parasite isolates. However, introduction of the F446I mutation in k13 of the 3D7 and FCC1/HN isolates led to elevated ring survival rates detected using RSA when subjected to both 700 and 20 nM concentrations of dihydroartemisinin. The survival rates were similar to those detected in the parasite lines with the C580Y mutation.
Insertion of the F446I mutation in k13 led to increased ring survival, suggesting that this mutation may be associated with ART resistance and could be used as a molecular marker for monitoring ART-resistant parasites. The results also highlights the importance of surveillance of F446I mutants for containing the resistant parasite.
恶性疟原虫 k13 基因突变与青蒿素(ART)耐药性有关。然而,在中国-缅甸边境和缅甸北部最常见的等位基因 F446I 是否与 ART 耐药性有关尚不清楚。因此,本研究旨在通过生成表达 F446I 突变等位基因的转基因寄生虫来研究该突变在 ART 耐药性中的作用。
通过单交叉重组生成携带 F446I 或 C580Y 突变的 3D7 和 FCC1/HN 分离株的转基因寄生虫,并通过 PCR 和基因测序进行验证。使用 0-3 小时环期生存测定(RSA)评估转基因寄生虫在体外对 ART 的敏感性。
成功生成了四个名为 3D7、3D7、FCC1/HN 和 FCC1/HN 的转基因寄生虫系。与亲本寄生虫分离株相比,这些寄生虫系的 k13 表达水平没有变化。然而,在 3D7 和 FCC1/HN 分离株的 k13 中引入 F446I 突变会导致 RSA 检测到的环存活率升高,当受到 700 和 20 nM 二氢青蒿素浓度的作用时。存活率与携带 C580Y 突变的寄生虫系相似。
k13 中的 F446I 突变导致环存活率增加,表明该突变可能与 ART 耐药性有关,可作为监测 ART 耐药寄生虫的分子标记。结果还强调了监测 F446I 突变体以控制耐药寄生虫的重要性。